0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Stem Cell Biomanufacturing Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-14F18753
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Stem Cell Biomanufacturing Market Research Report 2024
BUY CHAPTERS

Global Stem Cell Biomanufacturing Market Research Report 2024

Code: QYRE-Auto-14F18753
Report
November 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Stem Cell Biomanufacturing Market Size

The global market for Stem Cell Biomanufacturing was valued at US$ 1517 million in the year 2023 and is projected to reach a revised size of US$ 3389 million by 2030, growing at a CAGR of 12.1% during the forecast period.

Stem Cell Biomanufacturing Market

Stem Cell Biomanufacturing Market

Cell therapy biomanufacturing is a comprehensive field that involves the use of biotechnology and engineering principles to produce cell therapy products. Cell therapy biomanufacturing refers to the process of producing, processing and optimizing cells as drugs or treatments through a series of complex bioprocesses. These processes include cell isolation, culture, expansion, modification, and final formulation and quality control, aiming to produce safe, effective and therapeutic cell products. This report mainly focuses on stem cell biomanufacturing market.
North American market for Stem Cell Biomanufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Stem Cell Biomanufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Stem Cell Biomanufacturing in Skeletal Muscle Repair is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Stem Cell Biomanufacturing include Biosenic, Bristol-Myers Squibb, Danaher Life Sciences, Iovance Biotherapeutics, Lisata Therapeutics, Lonza, Merck KGaA, Thermo Fisher Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Stem Cell Biomanufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Biomanufacturing.
The Stem Cell Biomanufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cell Biomanufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Biomanufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Stem Cell Biomanufacturing Market Report

Report Metric Details
Report Name Stem Cell Biomanufacturing Market
Accounted market size in year US$ 1517 million
Forecasted market size in 2030 US$ 3389 million
CAGR 12.1%
Base Year year
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biosenic, Bristol-Myers Squibb, Danaher Life Sciences, Iovance Biotherapeutics, Lisata Therapeutics, Lonza, Merck KGaA, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Stem Cell Biomanufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Stem Cell Biomanufacturing Market growing?

Ans: The Stem Cell Biomanufacturing Market witnessing a CAGR of 12.1% during the forecast period 2024-2030.

What is the Stem Cell Biomanufacturing Market size in 2030?

Ans: The Stem Cell Biomanufacturing Market size in 2030 will be US$ 3389 million.

Who are the main players in the Stem Cell Biomanufacturing Market report?

Ans: The main players in the Stem Cell Biomanufacturing Market are Biosenic, Bristol-Myers Squibb, Danaher Life Sciences, Iovance Biotherapeutics, Lisata Therapeutics, Lonza, Merck KGaA, Thermo Fisher Scientific

What are the Application segmentation covered in the Stem Cell Biomanufacturing Market report?

Ans: The Applications covered in the Stem Cell Biomanufacturing Market report are Skeletal Muscle Repair, Bone Repair, Cancer, Cardiovascular Diseases, Neurological Disorders, Others

What are the Type segmentation covered in the Stem Cell Biomanufacturing Market report?

Ans: The Types covered in the Stem Cell Biomanufacturing Market report are Equipment, Software, Consumables

Recommended Reports

Cell Culture Technology

Stem Cell Products

Regenerative Medicine

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Biomanufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Equipment
1.2.3 Software
1.2.4 Consumables
1.3 Market by Application
1.3.1 Global Stem Cell Biomanufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Skeletal Muscle Repair
1.3.3 Bone Repair
1.3.4 Cancer
1.3.5 Cardiovascular Diseases
1.3.6 Neurological Disorders
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Biomanufacturing Market Perspective (2019-2030)
2.2 Global Stem Cell Biomanufacturing Growth Trends by Region
2.2.1 Global Stem Cell Biomanufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Stem Cell Biomanufacturing Historic Market Size by Region (2019-2024)
2.2.3 Stem Cell Biomanufacturing Forecasted Market Size by Region (2025-2030)
2.3 Stem Cell Biomanufacturing Market Dynamics
2.3.1 Stem Cell Biomanufacturing Industry Trends
2.3.2 Stem Cell Biomanufacturing Market Drivers
2.3.3 Stem Cell Biomanufacturing Market Challenges
2.3.4 Stem Cell Biomanufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Biomanufacturing Players by Revenue
3.1.1 Global Top Stem Cell Biomanufacturing Players by Revenue (2019-2024)
3.1.2 Global Stem Cell Biomanufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Stem Cell Biomanufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Stem Cell Biomanufacturing Revenue
3.4 Global Stem Cell Biomanufacturing Market Concentration Ratio
3.4.1 Global Stem Cell Biomanufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Biomanufacturing Revenue in 2023
3.5 Global Key Players of Stem Cell Biomanufacturing Head office and Area Served
3.6 Global Key Players of Stem Cell Biomanufacturing, Product and Application
3.7 Global Key Players of Stem Cell Biomanufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Biomanufacturing Breakdown Data by Type
4.1 Global Stem Cell Biomanufacturing Historic Market Size by Type (2019-2024)
4.2 Global Stem Cell Biomanufacturing Forecasted Market Size by Type (2025-2030)
5 Stem Cell Biomanufacturing Breakdown Data by Application
5.1 Global Stem Cell Biomanufacturing Historic Market Size by Application (2019-2024)
5.2 Global Stem Cell Biomanufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Stem Cell Biomanufacturing Market Size (2019-2030)
6.2 North America Stem Cell Biomanufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Stem Cell Biomanufacturing Market Size by Country (2019-2024)
6.4 North America Stem Cell Biomanufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Biomanufacturing Market Size (2019-2030)
7.2 Europe Stem Cell Biomanufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Stem Cell Biomanufacturing Market Size by Country (2019-2024)
7.4 Europe Stem Cell Biomanufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Biomanufacturing Market Size (2019-2030)
8.2 Asia-Pacific Stem Cell Biomanufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Stem Cell Biomanufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Stem Cell Biomanufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stem Cell Biomanufacturing Market Size (2019-2030)
9.2 Latin America Stem Cell Biomanufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Stem Cell Biomanufacturing Market Size by Country (2019-2024)
9.4 Latin America Stem Cell Biomanufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Biomanufacturing Market Size (2019-2030)
10.2 Middle East & Africa Stem Cell Biomanufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Stem Cell Biomanufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Stem Cell Biomanufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biosenic
11.1.1 Biosenic Company Details
11.1.2 Biosenic Business Overview
11.1.3 Biosenic Stem Cell Biomanufacturing Introduction
11.1.4 Biosenic Revenue in Stem Cell Biomanufacturing Business (2019-2024)
11.1.5 Biosenic Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Stem Cell Biomanufacturing Introduction
11.2.4 Bristol-Myers Squibb Revenue in Stem Cell Biomanufacturing Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Danaher Life Sciences
11.3.1 Danaher Life Sciences Company Details
11.3.2 Danaher Life Sciences Business Overview
11.3.3 Danaher Life Sciences Stem Cell Biomanufacturing Introduction
11.3.4 Danaher Life Sciences Revenue in Stem Cell Biomanufacturing Business (2019-2024)
11.3.5 Danaher Life Sciences Recent Development
11.4 Iovance Biotherapeutics
11.4.1 Iovance Biotherapeutics Company Details
11.4.2 Iovance Biotherapeutics Business Overview
11.4.3 Iovance Biotherapeutics Stem Cell Biomanufacturing Introduction
11.4.4 Iovance Biotherapeutics Revenue in Stem Cell Biomanufacturing Business (2019-2024)
11.4.5 Iovance Biotherapeutics Recent Development
11.5 Lisata Therapeutics
11.5.1 Lisata Therapeutics Company Details
11.5.2 Lisata Therapeutics Business Overview
11.5.3 Lisata Therapeutics Stem Cell Biomanufacturing Introduction
11.5.4 Lisata Therapeutics Revenue in Stem Cell Biomanufacturing Business (2019-2024)
11.5.5 Lisata Therapeutics Recent Development
11.6 Lonza
11.6.1 Lonza Company Details
11.6.2 Lonza Business Overview
11.6.3 Lonza Stem Cell Biomanufacturing Introduction
11.6.4 Lonza Revenue in Stem Cell Biomanufacturing Business (2019-2024)
11.6.5 Lonza Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Company Details
11.7.2 Merck KGaA Business Overview
11.7.3 Merck KGaA Stem Cell Biomanufacturing Introduction
11.7.4 Merck KGaA Revenue in Stem Cell Biomanufacturing Business (2019-2024)
11.7.5 Merck KGaA Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Stem Cell Biomanufacturing Introduction
11.8.4 Thermo Fisher Scientific Revenue in Stem Cell Biomanufacturing Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Stem Cell Biomanufacturing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Equipment
 Table 3. Key Players of Software
 Table 4. Key Players of Consumables
 Table 5. Global Stem Cell Biomanufacturing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Stem Cell Biomanufacturing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Stem Cell Biomanufacturing Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Stem Cell Biomanufacturing Market Share by Region (2019-2024)
 Table 9. Global Stem Cell Biomanufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Stem Cell Biomanufacturing Market Share by Region (2025-2030)
 Table 11. Stem Cell Biomanufacturing Market Trends
 Table 12. Stem Cell Biomanufacturing Market Drivers
 Table 13. Stem Cell Biomanufacturing Market Challenges
 Table 14. Stem Cell Biomanufacturing Market Restraints
 Table 15. Global Stem Cell Biomanufacturing Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Stem Cell Biomanufacturing Market Share by Players (2019-2024)
 Table 17. Global Top Stem Cell Biomanufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Biomanufacturing as of 2023)
 Table 18. Ranking of Global Top Stem Cell Biomanufacturing Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Stem Cell Biomanufacturing Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Stem Cell Biomanufacturing, Headquarters and Area Served
 Table 21. Global Key Players of Stem Cell Biomanufacturing, Product and Application
 Table 22. Global Key Players of Stem Cell Biomanufacturing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Stem Cell Biomanufacturing Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Stem Cell Biomanufacturing Revenue Market Share by Type (2019-2024)
 Table 26. Global Stem Cell Biomanufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Stem Cell Biomanufacturing Revenue Market Share by Type (2025-2030)
 Table 28. Global Stem Cell Biomanufacturing Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Stem Cell Biomanufacturing Revenue Market Share by Application (2019-2024)
 Table 30. Global Stem Cell Biomanufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Stem Cell Biomanufacturing Revenue Market Share by Application (2025-2030)
 Table 32. North America Stem Cell Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Stem Cell Biomanufacturing Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Stem Cell Biomanufacturing Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Stem Cell Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Stem Cell Biomanufacturing Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Stem Cell Biomanufacturing Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Stem Cell Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Stem Cell Biomanufacturing Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Stem Cell Biomanufacturing Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Stem Cell Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Stem Cell Biomanufacturing Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Stem Cell Biomanufacturing Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Stem Cell Biomanufacturing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Stem Cell Biomanufacturing Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Stem Cell Biomanufacturing Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Biosenic Company Details
 Table 48. Biosenic Business Overview
 Table 49. Biosenic Stem Cell Biomanufacturing Product
 Table 50. Biosenic Revenue in Stem Cell Biomanufacturing Business (2019-2024) & (US$ Million)
 Table 51. Biosenic Recent Development
 Table 52. Bristol-Myers Squibb Company Details
 Table 53. Bristol-Myers Squibb Business Overview
 Table 54. Bristol-Myers Squibb Stem Cell Biomanufacturing Product
 Table 55. Bristol-Myers Squibb Revenue in Stem Cell Biomanufacturing Business (2019-2024) & (US$ Million)
 Table 56. Bristol-Myers Squibb Recent Development
 Table 57. Danaher Life Sciences Company Details
 Table 58. Danaher Life Sciences Business Overview
 Table 59. Danaher Life Sciences Stem Cell Biomanufacturing Product
 Table 60. Danaher Life Sciences Revenue in Stem Cell Biomanufacturing Business (2019-2024) & (US$ Million)
 Table 61. Danaher Life Sciences Recent Development
 Table 62. Iovance Biotherapeutics Company Details
 Table 63. Iovance Biotherapeutics Business Overview
 Table 64. Iovance Biotherapeutics Stem Cell Biomanufacturing Product
 Table 65. Iovance Biotherapeutics Revenue in Stem Cell Biomanufacturing Business (2019-2024) & (US$ Million)
 Table 66. Iovance Biotherapeutics Recent Development
 Table 67. Lisata Therapeutics Company Details
 Table 68. Lisata Therapeutics Business Overview
 Table 69. Lisata Therapeutics Stem Cell Biomanufacturing Product
 Table 70. Lisata Therapeutics Revenue in Stem Cell Biomanufacturing Business (2019-2024) & (US$ Million)
 Table 71. Lisata Therapeutics Recent Development
 Table 72. Lonza Company Details
 Table 73. Lonza Business Overview
 Table 74. Lonza Stem Cell Biomanufacturing Product
 Table 75. Lonza Revenue in Stem Cell Biomanufacturing Business (2019-2024) & (US$ Million)
 Table 76. Lonza Recent Development
 Table 77. Merck KGaA Company Details
 Table 78. Merck KGaA Business Overview
 Table 79. Merck KGaA Stem Cell Biomanufacturing Product
 Table 80. Merck KGaA Revenue in Stem Cell Biomanufacturing Business (2019-2024) & (US$ Million)
 Table 81. Merck KGaA Recent Development
 Table 82. Thermo Fisher Scientific Company Details
 Table 83. Thermo Fisher Scientific Business Overview
 Table 84. Thermo Fisher Scientific Stem Cell Biomanufacturing Product
 Table 85. Thermo Fisher Scientific Revenue in Stem Cell Biomanufacturing Business (2019-2024) & (US$ Million)
 Table 86. Thermo Fisher Scientific Recent Development
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources
 Table 90. Authors List of This Report


List of Figures
 Figure 1. Stem Cell Biomanufacturing Picture
 Figure 2. Global Stem Cell Biomanufacturing Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Stem Cell Biomanufacturing Market Share by Type: 2023 VS 2030
 Figure 4. Equipment Features
 Figure 5. Software Features
 Figure 6. Consumables Features
 Figure 7. Global Stem Cell Biomanufacturing Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Stem Cell Biomanufacturing Market Share by Application: 2023 VS 2030
 Figure 9. Skeletal Muscle Repair Case Studies
 Figure 10. Bone Repair Case Studies
 Figure 11. Cancer Case Studies
 Figure 12. Cardiovascular Diseases Case Studies
 Figure 13. Neurological Disorders Case Studies
 Figure 14. Others Case Studies
 Figure 15. Stem Cell Biomanufacturing Report Years Considered
 Figure 16. Global Stem Cell Biomanufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 17. Global Stem Cell Biomanufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 18. Global Stem Cell Biomanufacturing Market Share by Region: 2023 VS 2030
 Figure 19. Global Stem Cell Biomanufacturing Market Share by Players in 2023
 Figure 20. Global Top Stem Cell Biomanufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Biomanufacturing as of 2023)
 Figure 21. The Top 10 and 5 Players Market Share by Stem Cell Biomanufacturing Revenue in 2023
 Figure 22. North America Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. North America Stem Cell Biomanufacturing Market Share by Country (2019-2030)
 Figure 24. United States Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Canada Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Europe Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Europe Stem Cell Biomanufacturing Market Share by Country (2019-2030)
 Figure 28. Germany Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. France Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. U.K. Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Italy Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Russia Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Nordic Countries Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Asia-Pacific Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Asia-Pacific Stem Cell Biomanufacturing Market Share by Region (2019-2030)
 Figure 36. China Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Japan Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. South Korea Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. India Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Australia Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Latin America Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Latin America Stem Cell Biomanufacturing Market Share by Country (2019-2030)
 Figure 44. Mexico Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Brazil Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East & Africa Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Middle East & Africa Stem Cell Biomanufacturing Market Share by Country (2019-2030)
 Figure 48. Turkey Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. UAE Stem Cell Biomanufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Biosenic Revenue Growth Rate in Stem Cell Biomanufacturing Business (2019-2024)
 Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Stem Cell Biomanufacturing Business (2019-2024)
 Figure 53. Danaher Life Sciences Revenue Growth Rate in Stem Cell Biomanufacturing Business (2019-2024)
 Figure 54. Iovance Biotherapeutics Revenue Growth Rate in Stem Cell Biomanufacturing Business (2019-2024)
 Figure 55. Lisata Therapeutics Revenue Growth Rate in Stem Cell Biomanufacturing Business (2019-2024)
 Figure 56. Lonza Revenue Growth Rate in Stem Cell Biomanufacturing Business (2019-2024)
 Figure 57. Merck KGaA Revenue Growth Rate in Stem Cell Biomanufacturing Business (2019-2024)
 Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Stem Cell Biomanufacturing Business (2019-2024)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart